다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
The International journal of biological markers, v.22 no.3, 2007년, pp.206 - 213
Scaramuzzino, D.A. (DOCRO, Inc., Seymour, CT) , Schulte, K. (Ellis Hospital Laboratory, Schenectady, NY) , Mack, B.N. (DOCRO, Inc., Seymour, CT) , Soriano, T.F. (DOCRO, Inc., Seymour, CT) , Fritsche, H.A. (Department of Laboratory Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX - USA)
AI-Helper
The stability of total (t) and free (f) prostate-specific antigen (PSA) in male serum specimens stored at -70°C or lower temperature for 4.7 to 4.9 years was studied. Until now, the stability of these analytes in serum has not been evaluated systematically beyond 2 years of storage at -70°C....
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Thun, M. J.. Cancer Statistics, 2007. CA: A Cancer Journal for Clinicians, vol.57, no.1, 43-66.
Biotechnol Appl Biochem Bedzyk W.D. 249 27 1998 10.1111/j.1470-8744.1998.tb00502.x
Oesterling, Joseph E.. Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate. The Journal of urology : official journal of the American Urological Association, Inc, vol.145, no.5, 907-923.
christensson, Anders, Björk, Thomas, Nilsson, Olle, Dahlén, Ulrika, Matikainen, Marja-Terttu, Cockett, Abraham T.K., Abrahamsson, Per-Anders, Lilja, Hans. Serum Prostate Specific Antigen Complexed toα1-Antichymotrypsin as an Indicator of Prostate Cancer. The Journal of urology : official journal of the American Urological Association, Inc, vol.150, no.1, 100-105.
Cancer Res Stenman U.H. 222 51 1991
Luderer, Albert A., Chen, Ya-Ting, Soriano, Thomas F., Kramp, William J., Carlson, Grant, Cuny, Carol, Sharp, Thomas, Smith, William, Petteway, Jason, Brawer, Michael K., Thiel, Robert. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology, vol.46, no.2, 187-194.
Catalona, W J, Smith, D S, Wolfert, R L, Wang, T J, Rittenhouse, H G, Ratliff, T L, Nadler, R B. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.. JAMA : the journal of the American Medical Association, vol.274, no.15, 1214-1220.
Pearson, Jay D., Luderer, Albert A., Jeffrey Metter, E., Partin, Alan W., Chan, Daniel W., Fozard, James L., Ballentine Carter, H.. Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer. Urology, vol.48, no.6, 4-9.
Froschermaier, Stefan E., Pilarsky, Christian P., Wirth, Manfred P.. Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinoma. Urology, vol.47, no.4, 525-528.
Marley, Garry M., Craig Miller, M., Kattan, Michael W., Zhao, Gang, Patton, Kevin P., Vessella, Robert L., Wright Jr., George L., Schellhammer Jr., Paul F., Veltri Jr., Robert W.. Free and complexed prostate-specific antigen serum ratios to predict probability of primary prostate cancer and benign prostatic hyperplasia. Urology, vol.48, no.6, 16-22.
Partin, Alan W., Catalona, William J., Southwick, Paula C., Subong, Eric N.P., Gasior, Gail H., Chan, Daniel W.. Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total psa, prostate volume, and age. Urology, vol.48, no.6, 55-61.
Chen, Ya-Ting, Luderer, Albert A., Thiel, Robert P., Carlson, Grant, Cuny, Carole L., Soriano, Thomas E.. Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer. Urology, vol.47, no.4, 518-524.
Catalona, W J, Partin, A W, Slawin, K M, Brawer, M K, Flanigan, R C, Patel, A, Richie, J P, deKernion, J B, Walsh, P C, Scardino, P T, Lange, P H, Subong, E N, Parson, R E, Gasior, G H, Loveland, K G, Southwick, P C. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.. JAMA : the journal of the American Medical Association, vol.279, no.19, 1542-1547.
Woodrum, David, French, Chet, Blair Shamel, L.. Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions. Urology, vol.48, no.6, 33-39.
Woodrum, David, York, Lisa. Two-year stability of free and total PSA in frozen serum samples. Urology, vol.52, no.2, 247-251.
Piironen, Timo, Pettersson, Kim, Suonpää, Mikko, Stenman, Ulf-Hkan, Oesterling, Joseph E., Lövgren, Timo, Lilja, Hans. In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to α1-antichymotrypsin in blood samples. Urology, vol.48, no.6, 81-87.
Arcangeli, Carlos G., Smith, Deborah S., Ratliff, Timothy L., Catalona, William J.. STABILITY OF SERUM TOTAL AND FREE PROSTATE SPECIFIC ANTIGEN UNDER VARYING STORAGE INTERVALS AND TEMPERATURES. The Journal of urology : official journal of the American Urological Association, Inc, vol.158, no.6, 2182-2187.
Clin Chem Jung K. 685 44 1998 10.1093/clinchem/44.3.685
Jung, Klaus, Lein, Michael, Brux, Brigitte, Sinha, Pranav, Schnorr, Dietmar, Loening, Stefan A.. Different Stability of Free and Complexed Prostate-Specific Antigen in Serum in Relation to Specimen Handling and Storage Conditions. Clinical chemistry and laboratory medicine : CCLM, vol.38, no.12, 1271-1276.
Leinonen, Jari, Stenman, Ulf-Håkan. Reduced Stability of Prostate-Specific Antigen after Long-Term Storage of Serum at -20°C. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, vol.21, no.1, 46-53.
Ulmert, David, Becker, Charlotte, Nilsson, Jan-Åke, Piironen, Timo, Björk, Thomas, Hugosson, Jonas, Berglund, Göran, Lilja, Hans. Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at −20 °C. Clinical chemistry, vol.52, no.2, 235-239.
PAUS, ELISABETH, NILSSON, OLLE, BORMER, OLE P., FOSSA, SOPHIE D., OTNES, BRYNJULF, SKOVLUND, EVA. STABILITY OF FREE AND TOTAL PROSTATE SPECIFIC ANTIGEN IN SERUM FROM PATIENTS WITH PROSTATE CARCINOMA AND BENIGN HYPERPLASIA. The Journal of urology : official journal of the American Urological Association, Inc, vol.159, no.5, 1599-1605.
Cartledge,, Thompson,, Verril,, Clarkson,, Eardley,. The stability of free and bound prostate‐specific antigen. BJU international, vol.84, no.7, 810-814.
Sokoll, Lori J, Bruzek, Debra J, Dua, Renu, Dunn, Willard, Mohr, Phaedre, Wallerson, Gail, Eisenberger, Mario, Partin, Alan W, Chan, Daniel W. Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigen. Urology, vol.60, no.4, 24-30.
Clin Chem Simm B. 113 37 1991 10.1093/clinchem/37.1.113
Statistical adjustment of data. Deming W.E. 1984
Clin Chem Cornbleet P.J. 432 25 1979 10.1093/clinchem/25.3.432
10.1002/9780470773666
Martin Bland, J., Altman, D.. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT. The Lancet, vol.327, no.8476, 307-310.
Bland, J Martin, Altman, Douglas G. Measuring agreement in method comparison studies. Statistical methods in medical research, vol.8, no.2, 135-160.
Clin Chem Dewitte K. 799 48 2002 10.1093/clinchem/48.5.799
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.